12:09 PM EST, 03/07/2025 (MT Newswires) -- BioNexus Gene Lab ( BGLC ) said it is partnering with ML Tech to optimize its Ethereum-focused treasury strategy.

The company said it plans to leverage ML Tech's digital asset trading infrastructure to grow its Ethereum holdings. ML Tech is a wealth management platform for digital assets.

Shares of the company were up over 3% in recent trading.

Price: 0.36, Change: +0.01, Percent Change: +3.77